DE2822731A1 - Vaccine zur immuntherapie neoplastischer erkrankungen - Google Patents

Vaccine zur immuntherapie neoplastischer erkrankungen

Info

Publication number
DE2822731A1
DE2822731A1 DE19782822731 DE2822731A DE2822731A1 DE 2822731 A1 DE2822731 A1 DE 2822731A1 DE 19782822731 DE19782822731 DE 19782822731 DE 2822731 A DE2822731 A DE 2822731A DE 2822731 A1 DE2822731 A1 DE 2822731A1
Authority
DE
Germany
Prior art keywords
cancer
cells
manganese
vaccine
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19782822731
Other languages
German (de)
English (en)
Inventor
Duncan Lee Mccollester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE2822731A1 publication Critical patent/DE2822731A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19782822731 1978-04-20 1978-05-24 Vaccine zur immuntherapie neoplastischer erkrankungen Withdrawn DE2822731A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89812278A 1978-04-20 1978-04-20

Publications (1)

Publication Number Publication Date
DE2822731A1 true DE2822731A1 (de) 1979-10-31

Family

ID=25408978

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782822731 Withdrawn DE2822731A1 (de) 1978-04-20 1978-05-24 Vaccine zur immuntherapie neoplastischer erkrankungen

Country Status (11)

Country Link
JP (1) JPS54154506A (enrdf_load_stackoverflow)
AU (1) AU519008B2 (enrdf_load_stackoverflow)
BE (1) BE867410A (enrdf_load_stackoverflow)
DE (1) DE2822731A1 (enrdf_load_stackoverflow)
FR (1) FR2423223A1 (enrdf_load_stackoverflow)
GB (1) GB1603597A (enrdf_load_stackoverflow)
IE (1) IE47736B1 (enrdf_load_stackoverflow)
IN (1) IN149012B (enrdf_load_stackoverflow)
MX (1) MX5759E (enrdf_load_stackoverflow)
NL (1) NL7805501A (enrdf_load_stackoverflow)
PH (1) PH14990A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19519492A1 (de) * 1995-05-27 1996-11-28 Miele & Cie Tragvorrichtung für metallische Werkstücke

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2900184A (en) * 1983-06-10 1984-12-13 Richard F. Martin Membrane antigens generated from pooled cells and monoclonal antibodies
GB8321009D0 (en) * 1983-08-04 1983-09-07 New R R C Immunological compositions
CN1100569C (zh) * 1997-01-24 2003-02-05 石桂秀 肿瘤疫苗制备方法
EP4025245A1 (en) * 2019-09-04 2022-07-13 VCell Therapeutics, Inc. Vaccine for treatment of cancer and method of making by stress reprogramming
WO2025028658A1 (ja) * 2023-08-03 2025-02-06 国立大学法人東京農工大学 免疫増強剤及び免疫増強方法並びにタンパク質の凝集体及び／又は会合体の製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065141A (en) * 1960-08-24 1962-11-20 Albert E Gessler Separation of nucleoproteins and nucleic acids from aqueous protein mixtures
DE1767196A1 (de) * 1967-04-11 1972-07-06 Rand Dev Corp Loesliche Krebsantigene,die an Fremdproteine gebunden sind
US4053586A (en) * 1971-10-08 1977-10-11 Intermountain Laboratories, Inc. Preparation for treating squamous cell carcinoma and method for making same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617865A1 (de) * 1966-03-12 1971-09-02 Karl Dr Med Theurer Verfahren zur Herstellung von Arzneimitteln gegen Krebs
GB1291134A (en) * 1970-01-21 1972-09-27 Anvar A process for the production of mammal cell anti-sera
ZA782613B (en) * 1978-05-08 1979-12-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065141A (en) * 1960-08-24 1962-11-20 Albert E Gessler Separation of nucleoproteins and nucleic acids from aqueous protein mixtures
DE1767196A1 (de) * 1967-04-11 1972-07-06 Rand Dev Corp Loesliche Krebsantigene,die an Fremdproteine gebunden sind
US4053586A (en) * 1971-10-08 1977-10-11 Intermountain Laboratories, Inc. Preparation for treating squamous cell carcinoma and method for making same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MAYR et al: Virolog Arbeitsmethoden, Fischer, Stuttgart, 1974, S.302 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19519492A1 (de) * 1995-05-27 1996-11-28 Miele & Cie Tragvorrichtung für metallische Werkstücke

Also Published As

Publication number Publication date
AU3605978A (en) 1979-11-15
MX5759E (es) 1984-06-28
NL7805501A (nl) 1979-10-23
IN149012B (enrdf_load_stackoverflow) 1981-08-15
PH14990A (en) 1982-03-12
FR2423223B1 (enrdf_load_stackoverflow) 1983-07-29
JPS54154506A (en) 1979-12-05
AU519008B2 (en) 1981-11-05
GB1603597A (en) 1981-11-25
FR2423223A1 (fr) 1979-11-16
IE47736B1 (en) 1984-06-13
IE780974L (en) 1979-10-20
BE867410A (fr) 1978-11-24

Similar Documents

Publication Publication Date Title
DE3852221T2 (de) Tierische Zelle mit darin eingeführtem antigenem Protein.
DE69732225T2 (de) Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
DE69429186T2 (de) Liposomen, die materialien in partikelform enthalten
DE69230381T2 (de) Rekonstituierte thrombozytenmembranvesikel
US4720386A (en) Vaccine and method for immunotherapy of neoplastic disease
DE2908241A1 (de) Bakterienzellenextrakt, verfahren zu seiner herstellung, diesen bakterienzellenextrakt enthaltende antitumoraktive zubereitung und adjuvanspraeparat
DE2656746C2 (de) Verwendung von beladenen Erythrozyten
EP0859628B9 (de) Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten
DD210217A5 (de) Verfahren zur herstellung stabiler plurilamellarer blaeschen
DD222783A5 (de) Verfahren zur herstellung eines antitumormittels
DE2638762A1 (de) Wasserloesliche adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69104362T2 (de) Autobiotika sowie deren verwendung bei der in vivo eliminierung körperfremder zellen.
DE2822731A1 (de) Vaccine zur immuntherapie neoplastischer erkrankungen
DD209736A5 (de) Verfahren zur herstellung zell- und geweberegenerierender stoffe
DE69829963T2 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE2325299A1 (de) Aus mikroorganismen von der art der mycobakterien erhaltene, nicht-spezifische reizmittel, die eine antitumorimmunitaet hervorrufen und verfahren zu deren herstellung
DE69838324T2 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
DE2650502C3 (de) Herstellung von Liposomen welche Arzneistoffe enthalten
DE3882061T2 (de) Verfahren zum Extrahieren von Membranantigenen mit immunogenen Eigenschaften aus humanen neoplastischen Zellen und so erhaltene Produkte.
DE3319360A1 (de) Pepsinartiges human-leukozyten-enzym, verfahren zur herstellung des enzyms und therapeutische zusammensetzung, welches dasselbe als wirkstoff enthaelt, sowie verwendung der zusammensetzung zur bekaempfung allergischer stoerungen, immunkomplex-erkrankungen und von tumoren
DE69420016T2 (de) Verwendung eines TMA-Komplexes und/oder eines Fragmentes dieses TMA Komplexes für die Herstellung eines Arzneimittels für die Behandlung und/oder die Vorbeugung von Krebs
DE2015804A1 (de) Verfahren zur Herstellung eines antigenen oder allergenen Extraktes
DE2134930A1 (de) Antigene Extrakte
DE3249251T1 (de) Therapeutische Mittel zur Behandlung von allergischen Störungen, Immunkomplexerkrankungen und Tumoren

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal